Related Experiment Video
Updated: May 12, 2026
05:53
Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease
Published on: July 18, 2019
C57BL/6 neuromuscular healthspan scoring system.
Ted G Graber1, Lisa Ferguson-Stegall, Jong-Hee Kim
1University of Minnesota Medical School, 420 Delaware St. SE, Minneapolis, MN 55455. thomp067@umn.edu.
Summary
Researchers developed a neuromuscular healthspan scoring system (NMHSS) using physiological and functional tests in aging mice. This new scoring system helps reduce variability and may improve the detection of treatment effects for sarcopenia and frailty.
Area of Science:
- Gerontology
- Animal Models
- Physiology
Background:
- Sarcopenia and frailty are age-related conditions impacting muscle health.
- Testing interventions in aging animal models requires robust outcome measures.
- Current assessment methods may have limitations in detecting subtle treatment effects.
Purpose of the Study:
- To develop and validate a comprehensive scoring system for neuromuscular healthspan in aging mice.
- To establish a reliable metric for assessing age-related decline in neuromuscular function.
- To create a tool that enhances the detection of therapeutic intervention efficacy.
Main Methods:
- Utilized male C57BL/6 mice across three age groups: adult, old, and elderly.
- Assessed functional performance using rotarod and inverted-cling grip tests.
- Measured in vitro muscle contractility and derived a composite neuromuscular healthspan scoring system (NMHSS).
Main Results:
- The NMHSS was derived by summing individual determinant scores.
- The scoring system demonstrated reduced individual variability within age groups compared to single measures.
- This suggests improved sensitivity for detecting treatment effects in future studies.
Conclusions:
- The developed neuromuscular healthspan scoring system (NMHSS) offers a promising tool for aging research.
- NMHSS may provide a more sensitive and reliable assessment of sarcopenia and frailty interventions.
- This scoring system can enhance the evaluation of therapeutic strategies targeting age-related neuromuscular decline.
